Delivery Order SPE2DB22D2009-SPE2DB25FL8NA
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a vaccine product. The contract has a firm fixed price of $7,391.70 and a completion date of January 28, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 720 Unit/0.5 ML syringes, a vaccine product, with a total ceiling value of $1,012.20. The contract is a firm fixed-price, non-set-aside agreement with a performance period through May 7, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,323.40, is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE medication. The contract is a Firm Fixed Price, non-set-aside award with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE, a pharmaceutical product. The contract has a ceiling value of $1,905.50 and an ultimate completion date of July 25, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds several Indefinite...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of HAVRIX 720 unit/0.5 ML syringes. The contract is a firm fixed-price delivery order with a ceiling value of $1,175.94 and an ultimate completion date of August 30, 2024. This contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML medical supplies, with a total ceiling value of $1,785.10. The contract is a firm fixed-price delivery order, with a period of performance ending on February 10, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the HAVRIX 1,440 UNIT/ML SYRINGE pharmaceutical product. The contract has a ceiling value of $6,790.40 and was awarded on July 12, 2022, with a completion date of July 13, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,839 units of the HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML vaccine, with a total ceiling value of $1,347.50. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HAVRIX 1,440 Unit/mL syringes. The contract has a ceiling value of $2,286.60 and a period of performance through September 9, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical products and supplies to the U.S. government,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,313.85 firm-fixed-price contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a vaccine product. The contract has an ultimate completion date of February 10, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...